Tim Holland‐Letz

15.3k total citations · 6 hit papers
118 papers, 7.8k citations indexed

About

Tim Holland‐Letz is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Tim Holland‐Letz has authored 118 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 30 papers in Radiology, Nuclear Medicine and Imaging and 24 papers in Oncology. Recurrent topics in Tim Holland‐Letz's work include Prostate Cancer Treatment and Research (22 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). Tim Holland‐Letz is often cited by papers focused on Prostate Cancer Treatment and Research (22 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). Tim Holland‐Letz collaborates with scholars based in Germany, Switzerland and United States. Tim Holland‐Letz's co-authors include Uwe Haberkorn, Ali Afshar‐Oromieh, Frederik L. Giesel, Clemens Kratochwil, Jürgen Debus, Matthias Eder, Klaus Kopka, Boris Hadaschik, Heinz Linhart and Michael Eisenhut and has published in prestigious journals such as Nature, Circulation and Nature Communications.

In The Last Decade

Tim Holland‐Letz

115 papers receiving 7.7k citations

Hit Papers

Identification of a popul... 2013 2026 2017 2021 2013 2014 2013 2015 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
    2013 836 citations Tim Holland‐Letz et al. profile →
  2. The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
    2014 785 citations Ali Afshar‐Oromieh, Frederik L. Giesel et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
  3. Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
    2013 712 citations Ali Afshar‐Oromieh, Christian M. Zechmann et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
  4. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo
    2015 513 citations Tim Holland‐Letz et al. profile →
  5. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    2017 400 citations Ali Afshar‐Oromieh, Tim Holland‐Letz et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
  6. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
    2015 332 citations Ali Afshar‐Oromieh, Clemens Kratochwil et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Holland‐Letz Germany 40 3.5k 2.7k 2.2k 1.1k 1.1k 118 7.8k
Mizuki Nishino United States 56 6.1k 1.8× 1.7k 0.6× 5.5k 2.5× 979 0.9× 1.4k 1.3× 228 10.9k
Bin S. Teh United States 48 4.0k 1.2× 1.6k 0.6× 2.0k 0.9× 1.1k 0.9× 1.2k 1.1× 374 8.4k
Guy Storme Belgium 48 6.0k 1.7× 2.9k 1.1× 2.2k 1.0× 1.8k 1.6× 1.0k 0.9× 255 10.8k
Christian Rübe Germany 38 3.4k 1.0× 2.3k 0.9× 1.4k 0.6× 741 0.7× 1.3k 1.2× 150 7.0k
Vamsidhar Velcheti United States 46 3.8k 1.1× 2.7k 1.0× 5.3k 2.4× 1.3k 1.1× 1.5k 1.3× 193 9.3k
Feng‐Ming Kong United States 55 6.0k 1.7× 4.9k 1.8× 2.1k 1.0× 931 0.8× 1.3k 1.2× 390 10.6k
Dirk De Ruysscher Netherlands 48 5.0k 1.5× 3.1k 1.2× 2.8k 1.3× 921 0.8× 930 0.8× 237 8.4k
Ingela Turesson Sweden 36 5.5k 1.6× 3.7k 1.4× 2.5k 1.1× 2.0k 1.8× 1.9k 1.8× 119 9.4k
Kan Yonemori Japan 38 1.9k 0.6× 1.0k 0.4× 3.8k 1.7× 898 0.8× 1.4k 1.2× 392 6.2k
Eleni Efstathiou United States 41 4.7k 1.4× 1.3k 0.5× 2.4k 1.1× 1.7k 1.5× 2.0k 1.8× 203 7.4k

Countries citing papers authored by Tim Holland‐Letz

Since Specialization
Citations

This map shows the geographic impact of Tim Holland‐Letz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Holland‐Letz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Holland‐Letz more than expected).

Fields of papers citing papers by Tim Holland‐Letz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Holland‐Letz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Holland‐Letz. The network helps show where Tim Holland‐Letz may publish in the future.

Co-authorship network of co-authors of Tim Holland‐Letz

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Holland‐Letz. A scholar is included among the top collaborators of Tim Holland‐Letz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Holland‐Letz. Tim Holland‐Letz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brenner, Hermann, Tim Holland‐Letz, Annette Kopp‐Schneider, Thomas Heisser, & Michael Hoffmeister. (2025). Early-detection and prevention effects of screening sigmoidoscopy: evidence from randomized trials revisited. JNCI Journal of the National Cancer Institute. 118(3). 422–428.
2.
Nguyen, Duy, Sara Najafi, Norman Mack, et al.. (2024). Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours. British Journal of Cancer. 131(4). 763–777. 1 indexed citations
3.
Brenner, Hermann, Tim Holland‐Letz, Annette Kopp‐Schneider, Thomas Heisser, & Michael Hoffmeister. (2024). Unraveling the effects of screening colonoscopy on colorectal cancer early detection and prevention: the NordICC trial revisited. Cancer Communications. 45(3). 205–208. 3 indexed citations
4.
Höhn, Julia, Eva Krieghoff‐Henning, Jitendra Jonnagaddala, et al.. (2023). Colorectal cancer risk stratification on histological slides based on survival curves predicted by deep learning. npj Precision Oncology. 7(1). 98–98. 5 indexed citations
5.
Koerber, Stefan A., Clemens Kratochwil, Ingmar Schlampp, et al.. (2021). Predicting the Risk of Metastases by PSMA-PET/CT—Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma. Cancers. 13(7). 1508–1508. 9 indexed citations
6.
Gebhardt, Christoffer, Rebekka Weber, Raphael Reinhard, et al.. (2020). Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular Immunology. 360. 104274–104274. 19 indexed citations
7.
Holland‐Letz, Tim & Annette Kopp‐Schneider. (2020). An R-shiny application to calculate optimal designs for single substance and interaction trials in dose response experiments. Toxicology Letters. 337. 18–27. 5 indexed citations
8.
Rathke, Hendrik, Tim Holland‐Letz, Walter Mier, et al.. (2019). Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase. Journal of Nuclear Medicine. 61(5). 689–695. 48 indexed citations
9.
Kesch, Claudia, Maria Vinsensia, Jan Philipp Radtke, et al.. (2017). Intraindividual Comparison of 18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study. Journal of Nuclear Medicine. 58(11). 1805–1810. 88 indexed citations
10.
Weber, Claudia E.M., Chonglin Luo, Agnes Hotz‐Wagenblatt, et al.. (2016). miR-339-3p Is a Tumor Suppressor in Melanoma. Cancer Research. 76(12). 3562–3571. 65 indexed citations
11.
Gebhardt, Christoffer, Alexandra Sevko, Huanhuan Jiang, et al.. (2015). Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab. Clinical Cancer Research. 21(24). 5453–5459. 290 indexed citations
12.
Kratochwil, Clemens, M. Stefanova, Eleni Mavriopoulou, et al.. (2014). SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors. Molecular Imaging and Biology. 17(3). 313–318. 165 indexed citations
13.
Afshar‐Oromieh, Ali, Christian M. Zechmann, Matthias Eder, et al.. (2013). Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 41(1). 11–20. 712 indexed citations breakdown →
14.
Holland‐Letz, Tim, Holger Dette, & Didier Renard. (2011). Efficient Algorithms for Optimal Designs with Correlated Observations in Pharmacokinetics and Dose‐Finding Studies. Biometrics. 68(1). 138–145. 6 indexed citations
15.
Diehm, Curt, Jens‐Rainer Allenberg, Roman L. Haberl, et al.. (2007). Abstract 3701: High All-Cause Mortality in Patients with Peripheral Arterial Disease in Primary Care: Five-Year Results of the getabi Study. Circulation. 116. 8 indexed citations
16.
Stachon, Axel, et al.. (2006). Poor prognosis indicated by nucleated red blood cells in peripheral blood is not associated with organ failure of the liver or kidney. Clinical Chemistry and Laboratory Medicine (CCLM). 44(8). 955–61. 21 indexed citations
17.
Hölzle, Frank, et al.. (2006). Electrical Ear Acupuncture Reduces Histamine-induced Itch (Alloknesis). Acta Dermato Venereologica. 86(5). 399–403. 21 indexed citations
18.
Stachon, Axel, et al.. (2006). Daily monitoring of nucleated red blood cells in the blood of surgical intensive care patients. Clinica Chimica Acta. 366(1-2). 329–335. 32 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mizuki Nishino Breakdown of academic impact, for papers by Bin S. Teh Breakdown of academic impact, for papers by Guy Storme Breakdown of academic impact, for papers by Christian Rübe Breakdown of academic impact, for papers by Vamsidhar Velcheti Breakdown of academic impact, for papers by Feng‐Ming Kong Breakdown of academic impact, for papers by Dirk De Ruysscher Breakdown of academic impact, for papers by Ingela Turesson Breakdown of academic impact, for papers by Kan Yonemori Breakdown of academic impact, for papers by Eleni Efstathiou
Rankless by CCL
2026